ClinicalTrials.Veeva

Menu

Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents

X

Xiaoyin Zhang

Status and phase

Unknown
Phase 4

Conditions

Pancreatic Pseudocyst

Treatments

Procedure: EUS-guided pancreatic pseudocyst drainage

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

EUS-guided pseudocyst drainage has been used world widely. Now, most endoscopists tend to place several stents to drain the content of cyst into GI tract. In the investigators experience, a modified naso-pancreatic tube drainage was more safer, easier and cheaper than placement of stents. Moreover, none of pseudocysts(total 19) drained by this modified naso-pancreatic tube drainage method were found recurrent with a follow up period from 3 months-34 months. So, the investigators designed this prospective random comparing study to confirm the result.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults with ages from 18-80 years old.
  2. The pseudocysts were formed more than 3 months.
  3. The size of pseudocyst is more than 5 cm.
  4. The patient has the symptoms related with the pseudocyst.
  5. The distance between gastric and the wall of the pseudocyst is less than 1 cm from CT image.
  6. The consent form has been signed.

Exclusion criteria

  1. The patient can't accept the endoscopic procedure.
  2. The patient has blood coagulation dysfunction.
  3. The patient has mental disorders.
  4. The patient has mild or severe cardiorespiratory insufficiency.
  5. The patient has hypertension and can't be controlled to safe level.
  6. Diabetics whose blood sugar level can't be controlled to safe level.
  7. Patients with alcohol dependence
  8. Pregnant and lactating women.
  9. The patients the investigator don't think suitable for this study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Naso-pancreatic tube
Experimental group
Description:
The patients enrolled in this group will be treated with modified naso-pancreatic tube drainage method.
Treatment:
Procedure: EUS-guided pancreatic pseudocyst drainage
Stents
Experimental group
Description:
The patients enrolled this group will be treated by placing the stents (at least 2 stents) between gastric and pancreatic pseudocyst.
Treatment:
Procedure: EUS-guided pancreatic pseudocyst drainage

Trial contacts and locations

1

Loading...

Central trial contact

Xin Wang, MD,PhD; Xiaoyin Zhang, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems